Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: Down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK+CD30+lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin

Cancer Research

Volumn 62, Issue 5, 2002, Pages 1559-1566

  Bonvini, Paolo ^a   Gastaldi, Tamara ^a   Falini, Brunangelo ^b   Rosolen, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; ANAPLASTIC LYMPHOMA KINASE; ANSAMYCIN DERIVATIVE; ANTINEOPLASTIC AGENT; BENZOQUINONE DERIVATIVE; CD30 ANTIGEN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HYBRID PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; NUCLEOPHOSMIN; PHOSPHOLIPASE C; PROTEIN SHC; PROTEIN TYROSINE KINASE; TYROSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LARGE CELL LYMPHOMA; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SRC HOMOLOGY DOMAIN; STEADY STATE;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD30; BENZOQUINONES; DOWN-REGULATION; ENZYME INHIBITORS; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; LYMPHOMA, LARGE-CELL; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RIFABUTIN; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0036494113     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
2. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
3. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)
4. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease
5. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum
6. Alk+ CD30+ lymphomas: A distinct molecular genetic subtype of non-Hodgkin's lymphoma
7. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
8. Detection of normal and chimeric nucleophosmin in human cells
9. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
10. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation
11. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)
12. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1a fibroblasts
13. Nucleophosminanaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity
14. Signal transduction by receptors with tyrosine kinase activity
15. The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation
16. Molecular chaperones and the art of recognizing a lost cause
17. Role of the heat shock response and molecular chaperones in oncogenesis and cell death
18. Differential interactions of p23 and the TPR-containing proteins Hop, Cyp40, FKBP52 and FKBP51 with Hsp90 mutants
19. The Hsp90 chaperone family
20. Stoichiometry, abundance and functional significance of the Hsp90/Hsp70-based multiprotein chaperone machinery in reticulocyte lysate
21. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo
22. The importance of ATP binding and hydrolysis by Hsp90 in formation and function of protein heterocomplexes
23. Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent
24. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signaling pathway
25. Geldanamycin-induced destabilization of Raf-1 involves the proteasome
26. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin
27. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: Essential role for stress proteins in oncogenic transformation
28. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules
29. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an Hsp90-binding agent
30. Geldanamycin as a potential anticancer agent: Its molecular target and biochemical activity
31. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin
32. ErbB-2 oncogene inhibition by geldanamycin derivatives: Synthesis, mechanism of action, and structure-activity relationships
33. DT-diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxy-geldanamycin, an inhibitor of heat shock protein 90
34. Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the Hsp 90 molecular chaperone
35. A ki-1 (CD-30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2:5 translocation and rearrangement of the T-cell receptor β-chain gene
36. v-src
37. Geldanamycin selectively destabilizes and conformationally alters mutated p53
38. The Hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase
39. Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinases
40. Geldanamycin induces ErbB-2 degradation by proteolitic fragmentation
41. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-ab1 and v-src proteins before their degradation by the proteasome
42. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome
43. The co-chaperone CHIP regulates protein triage decision mediated by heat-shock proteins
44. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation
45. The role of hsp70 in protection and repair of luciferase activity in vivo; experimental data and mathematical modelling
46. Role of the human heat shock protein Hsp70 in protection against stress-induced apoptosis
47. Molecular chaperones in cellular protein folding
48. Getting newly synthesized proteins into shape
49. CD30(+) anaplastic large cell lymphoma: A review of its histopathologic, genetic, and clinical features
50. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site
51. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice
52. Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity
53. Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model
54. The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation
55. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway
56. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis
57. Benzoquinoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition
58. The amino-terminal domain of heat shock protein 90 (Hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates Hsp90 conformation
59. c-erbB-2receptor protein-tyrosine kinase induced by geldanamycin
60. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association
61. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-Met-urokinase plasminogen activator-plasmin proteolytic network
62. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome
63. Herbimycin A induces the 20S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases
64. Hsp70 family molecular chaperones and mutant insulin receptor: Differential binding specificities of BIP and Hsp70/Hsc70 determines accumulation or degradation of insulin receptor
65. Involvement of heat shock protein 90 in the degradation of mutant insulin receptors by the proteasome
66. Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Ab1 levels and induces apoptosis and differentiation of Bcr-Ab1-positive human leukemic blasts
67. Hsp90: Chaperoning signal transduction
68. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90